Body Composition and Metabolic Changes in HIV-Infected Patients

Elevated triglycerides and risk of myocardial infarction in HIV-positive persons

(2011) Signe W. Worm et al.   AIDS

Decreased limb muscle and increased central adiposity are associated with 5-year all-cause mortality in HIV infection

(2011) Rebecca Scherzer et al.   AIDS

Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment

(2011) Jacqueline Capeau et al.   AIDS

Peripheral and Central Fat Changes in Subjects Randomized to Abacavir-Lamivudine or Tenofovir-Emtricitabine With Atazanavir-Ritonavir or Efavirenz: ACTG Study A5224s

(2011) G. A. McComsey et al.   CLINICAL INFECTIOUS DISEASES

Preferential Fat Deposition in SubcutaneousVersusVisceral Depots Is Associated with Insulin Sensitivity

(2011) Tracey McLaughlin et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Hypertriglyceridemia and Waist Circumference Predict Cardiovascular Risk among HIV Patients: A Cross-Sectional Study

(2011) Peter M. Janiszewski et al.   PLoS One

Regional adipose tissue measured by MRI over 5 years in HIV-infected and control participants indicates persistence of HIV-associated lipoatrophy

(2010) Carl Grunfeld et al.   AIDS

HIV-protease inhibitors suppress skeletal muscle fatty acid oxidation by reducing CD36 and CPT1 fatty acid transporters

(2010) Scott R. Richmond et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Association Between Systemic Inflammation and Incident Diabetes in HIV-Infected Patients After Initiation of Antiretroviral Therapy

(2010) T. T. Brown et al.   DIABETES CARE

Lipodystrophy: metabolic insights from a rare disorder

(2010) Isabel Huang-Doran et al.   JOURNAL OF ENDOCRINOLOGY

Effect of atazanavir and ritonavir on the differentiation and adipokine secretion of human subcutaneous and omental preadipocytes

(2009) Simon P Jones et al.   AIDS

HIV infection and the risk of diabetes mellitus

(2009) Adeel A Butt et al.   AIDS

Lipodystrophy and anti-retroviral therapy as predictors of sub-clinical atherosclerosis in human immunodeficiency virus infected subjects

(2009) Giovanni Guaraldi et al.   ATHEROSCLEROSIS

Antiretroviral Therapy is Associated With an Atherogenic Lipoprotein Phenotype Among HIV-1-Infected Men in the Multicenter AIDS Cohort Study

(2009) Sharon A Riddler et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

The Effect of Individual Antiretroviral Drugs on Body Composition in HIV-Infected Persons Initiating Highly Active Antiretroviral Therapy

(2009) Judith C Shlay et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

HIV-protease inhibitors induce expression of suppressor of cytokine signaling-1 in insulin-sensitive tissues and promote insulin resistance and type 2 diabetes mellitus

(2008) Michael J. Carper et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Incidence and Risk Factors for New-Onset Diabetes in HIV-Infected Patients: The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study

(2008) S. De Wit et al.   DIABETES CARE

The Associations of Regional Adipose Tissue With Lipid and Lipoprotein Levels in HIV-Infected Men

(2008) David Wohl et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Proinflammatory Markers, Insulin Sensitivity, and Cardiometabolic Risk Factors in Treated HIV Infection

(2008) Katherine Samaras et al.   Obesity